These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11605798)

  • 21. SPECT/CT study of bronchial deposition of inhaled particles. A human aerosol vaccination model against HPV.
    Ilic V; Dunet V; Le Pape A; Buchs M; Kosinski M; Bischof Delaloye A; Gerber S; Prior JO
    Nuklearmedizin; 2016 Sep; 55(5):203-8. PubMed ID: 27440125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human respiratory tract model for radiological protection: a revision of the ICRP Dosimetric Model for the Respiratory System.
    Bair WJ
    Health Phys; 1989; 57 Suppl 1():249-52; discussion 252-3. PubMed ID: 2606686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Respiratory deposition and inhalability of monodisperse aerosols in Long-Evans rats.
    Asgharian B; Kelly JT; Tewksbury EW
    Toxicol Sci; 2003 Jan; 71(1):104-11. PubMed ID: 12520080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Uncertainty analysis of the weighted equivalent lung dose per unit exposure to radon progeny in the home.
    Marsh JW; Birchall A; Butterweck G; Dorrian MD; Huet C; Ortega X; Reineking A; Tymen G; Schuler Ch; Vargas A; Vezzu G; Wendt J
    Radiat Prot Dosimetry; 2002; 102(3):229-48. PubMed ID: 12430962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regional Deposition: Deposition Models.
    Hofmann W
    J Aerosol Med Pulm Drug Deliv; 2020 Oct; 33(5):239-248. PubMed ID: 32758048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Model for the deposition of aerosol particles in the respiratory tract of the rat. I. Nonhygroscopic particle deposition.
    Schmid O; Bolle I; Harder V; Karg E; Takenaka S; Schulz H; Ferron GA
    J Aerosol Med Pulm Drug Deliv; 2008 Sep; 21(3):291-307. PubMed ID: 18627243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Models of deposition, pharmacokinetics, and intersubject variability in respiratory drug delivery.
    Martin AR; Moore CP; Finlay WH
    Expert Opin Drug Deliv; 2018 Dec; 15(12):1175-1188. PubMed ID: 30388902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro and in vivo lung deposition of coated magnetic aerosol particles.
    Xie Y; Longest PW; Xu YH; Wang JP; Wiedmann TS
    J Pharm Sci; 2010 Nov; 99(11):4658-68. PubMed ID: 20845463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of modeled estimates of inhalation exposure to aerosols during use of consumer spray products.
    Park J; Yoon C; Lee K
    Int J Hyg Environ Health; 2018 Jul; 221(6):941-950. PubMed ID: 29859667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Uncertainties in electron-absorbed fractions and lung doses from inhaled beta-emitters.
    Farfán EB; Bolch WE; Huston TE; Rajon DA; Huh C; Bolch WE
    Health Phys; 2005 Jan; 88(1):37-47. PubMed ID: 15596988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing the reliability of dose coefficients for exposure to radioiodine by members of the public, accounting for dosimetric and risk model uncertainties.
    Puncher M; Zhang W; Harrison JD; Wakeford R
    J Radiol Prot; 2017 Jun; 37(2):506-526. PubMed ID: 28586312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regional deposition in human lung of 2.5 microM particles.
    Svartengren M; Linnman L; Philipson K; Camner P
    Exp Lung Res; 1987; 12(4):265-79. PubMed ID: 3582281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simulation of deposition and clearance of inhaled particles in central human airways.
    Balásházy I; Farkas A; Szöke I; Hofmann W; Sturm R
    Radiat Prot Dosimetry; 2003; 105(1-4):129-32. PubMed ID: 14526942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A case series on lung deposition analysis of inhaled medication using functional imaging based computational fluid dynamics in asthmatic patients: effect of upper airway morphology and comparison with in vivo data.
    Vinchurkar S; Backer LD; Vos W; Holsbeke CV; Backer JD; Backer WD
    Inhal Toxicol; 2012; 24(2):81-8. PubMed ID: 22260527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regional deposition of inhaled 137 Cs-labeled monodisperse and polydisperse aluminosilicate aerosols in Syrian hamsters.
    Thomas RL; Raabe OG
    Am Ind Hyg Assoc J; 1978 Dec; 39(12):1009-18. PubMed ID: 742592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of Bayesian inference to the bioassay data from long-term follow-up of two refractory PuO2 inhalation cases.
    Avtandilashvili M; Brey R; Birchall A
    Health Phys; 2013 Apr; 104(4):394-404. PubMed ID: 23439143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of inhalation exposure modality and particle size on the respiratory deposition of ricin in BALB/c mice.
    Roy CJ; Hale M; Hartings JM; Pitt L; Duniho S
    Inhal Toxicol; 2003 May; 15(6):619-38. PubMed ID: 12692733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of respiratory drug delivery with enhanced condensational growth using an individual path model of the entire tracheobronchial airways.
    Tian G; Longest PW; Su G; Hindle M
    Ann Biomed Eng; 2011 Mar; 39(3):1136-53. PubMed ID: 21152983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mathematical model for the selective deposition of inhaled pharmaceuticals.
    Martonen TB
    J Pharm Sci; 1993 Dec; 82(12):1191-9. PubMed ID: 8308694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deposition of naphthalene and tetradecane vapors in models of the human respiratory system.
    Zhang Z; Kleinstreuer C
    Inhal Toxicol; 2011 Jan; 23(1):44-57. PubMed ID: 21222561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.